产品名称 | NebuSelect™ Recombinant Human OX40/TNFRSF4/CD134, hFc-tag |
---|---|
目录号 | NBL-242223 |
别名 | OX40/TNFRSF4/CD134; CD134; OX40; OX40L receptor; TNFRSF4; ACT-135; Ly-70; OX40 homologue;-TXGP1L; IMD16 |
外观 | see COA |
分子量 | Leu29-Ala216 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P43489 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242223-100ug | 100ug | Inquire | Inquire | |
NBL-242223-1mg | 1mg | Inquire | Inquire | |
NBL-242223-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human OX40/TNFRSF4/CD134, hFc-tag
Catalog#:
NBL-242223
Description:
NebuSelect™ Recombinant Human OX40/TNFRSF4/CD134, hFc-tag(Cat#NBL-242223) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Leu29-Ala216.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 46.8 kDa. Due to glycosylation, the protein migrates to 70-78 kDa based on Bis-Tris PAGE result.
Target Name:
OX40/TNFRSF4/CD134; CD134; OX40; OX40L receptor; TNFRSF4; ACT-135; Ly-70; OX40 homologue;-TXGP1L; IMD16
Target Information:
Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor. OX40 is a secondary co-stimulatory immune checkpoint molecule, expressed after 24 to 72 hours following activation; its ligand, OX40L, is also not expressed on resting antigen presenting cells, but is following their activation.
Amino Acid Sequence:
Leu29-Ala216
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.